vs
Embecta Corp.（EMBC）与Kosmos Energy Ltd.（KOS）财务数据对比。点击上方公司名可切换其他公司
Kosmos Energy Ltd.的季度营收约是Embecta Corp.的1.1倍（$294.6M vs $261.2M），Embecta Corp.同比增速更快（-0.3% vs -25.9%），过去两年Embecta Corp.的营收复合增速更高（-4.6% vs -16.5%）
Embecta Corp.是一家专注于糖尿病护理领域的全球医疗科技企业，主要设计、生产及销售胰岛素笔针、注射器、输注组件等给药装置，产品服务覆盖全球多个地区的患者、医疗机构及生物制药合作方。
科斯莫斯能源是一家美国上游石油企业，总部位于得克萨斯州达拉斯。公司目前在加纳、赤道几内亚近海以及墨西哥湾开展油气生产与开发业务，在毛里塔尼亚、塞内加尔近海拥有开发项目，还在纳米比亚、圣多美和普林西比、苏里南近海持有勘探许可。
EMBC vs KOS — 直观对比
营收规模更大
KOS
是对方的1.1倍
$261.2M
营收增速更快
EMBC
高出25.6%
-25.9%
两年增速更快
EMBC
近两年复合增速
-16.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $261.2M | $294.6M |
| 净利润 | $44.1M | — |
| 毛利率 | 61.9% | — |
| 营业利润率 | 31.9% | -125.7% |
| 净利率 | 16.9% | — |
| 营收同比 | -0.3% | -25.9% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.74 | $-0.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EMBCKOS
| Q4 25 | $261.2M | $294.6M | ||
| Q3 25 | $264.0M | $311.0M | ||
| Q2 25 | $295.5M | $392.6M | ||
| Q1 25 | $259.0M | $290.1M | ||
| Q4 24 | $261.9M | $397.6M | ||
| Q3 24 | $286.1M | $407.8M | ||
| Q2 24 | $272.5M | $447.8M | ||
| Q1 24 | $287.2M | $422.3M |
净利润EMBCKOS
| Q4 25 | $44.1M | — | ||
| Q3 25 | $26.4M | $-124.3M | ||
| Q2 25 | $45.5M | $-87.7M | ||
| Q1 25 | $23.5M | $-110.6M | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $14.6M | $45.0M | ||
| Q2 24 | $14.7M | $59.8M | ||
| Q1 24 | $28.9M | $91.7M |
毛利率EMBCKOS
| Q4 25 | 61.9% | — | ||
| Q3 25 | 60.0% | — | ||
| Q2 25 | 66.7% | — | ||
| Q1 25 | 63.4% | — | ||
| Q4 24 | 60.0% | — | ||
| Q3 24 | 60.7% | — | ||
| Q2 24 | 69.8% | — | ||
| Q1 24 | 64.6% | — |
营业利润率EMBCKOS
| Q4 25 | 31.9% | -125.7% | ||
| Q3 25 | 21.4% | -34.2% | ||
| Q2 25 | 31.8% | -16.2% | ||
| Q1 25 | 24.3% | -32.4% | ||
| Q4 24 | 11.0% | -8.5% | ||
| Q3 24 | 9.2% | 26.1% | ||
| Q2 24 | 20.5% | 30.2% | ||
| Q1 24 | 13.6% | 33.6% |
净利率EMBCKOS
| Q4 25 | 16.9% | — | ||
| Q3 25 | 10.0% | -40.0% | ||
| Q2 25 | 15.4% | -22.3% | ||
| Q1 25 | 9.1% | -38.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.1% | 11.0% | ||
| Q2 24 | 5.4% | 13.3% | ||
| Q1 24 | 10.1% | 21.7% |
每股收益（稀释后）EMBCKOS
| Q4 25 | $0.74 | $-0.80 | ||
| Q3 25 | $0.44 | $-0.26 | ||
| Q2 25 | $0.78 | $-0.18 | ||
| Q1 25 | $0.40 | $-0.23 | ||
| Q4 24 | $0.00 | $0.00 | ||
| Q3 24 | $0.24 | $0.09 | ||
| Q2 24 | $0.25 | $0.12 | ||
| Q1 24 | $0.50 | $0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $201.3M | $91.5M |
| 总债务越低越好 | — | $3.1B |
| 股东权益账面价值 | $-613.1M | $528.6M |
| 总资产 | $1.1B | $4.7B |
| 负债/权益比越低杠杆越低 | — | 5.78× |
8季度趋势，按日历期对齐
现金及短期投资EMBCKOS
| Q4 25 | $201.3M | $91.5M | ||
| Q3 25 | $225.5M | $64.0M | ||
| Q2 25 | $230.6M | $51.7M | ||
| Q1 25 | $209.3M | $49.8M | ||
| Q4 24 | $210.0M | $85.0M | ||
| Q3 24 | $267.5M | $51.6M | ||
| Q2 24 | $275.1M | $173.8M | ||
| Q1 24 | $299.8M | $254.3M |
总债务EMBCKOS
| Q4 25 | — | $3.1B | ||
| Q3 25 | $1.4B | $3.0B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益EMBCKOS
| Q4 25 | $-613.1M | $528.6M | ||
| Q3 25 | $-650.6M | $898.8M | ||
| Q2 25 | $-669.6M | $1.0B | ||
| Q1 25 | $-736.2M | $1.1B | ||
| Q4 24 | $-768.8M | $1.2B | ||
| Q3 24 | $-738.3M | $1.2B | ||
| Q2 24 | $-763.7M | $1.1B | ||
| Q1 24 | $-769.6M | $1.1B |
总资产EMBCKOS
| Q4 25 | $1.1B | $4.7B | ||
| Q3 25 | $1.1B | $5.1B | ||
| Q2 25 | $1.2B | $5.2B | ||
| Q1 25 | $1.1B | $5.3B | ||
| Q4 24 | $1.1B | $5.3B | ||
| Q3 24 | $1.3B | $5.5B | ||
| Q2 24 | $1.3B | $5.4B | ||
| Q1 24 | $1.2B | $5.4B |
负债/权益比EMBCKOS
| Q4 25 | — | 5.78× | ||
| Q3 25 | — | 3.31× | ||
| Q2 25 | — | 2.80× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.2M | $35.3M |
| 自由现金流经营现金流 - 资本支出 | $16.6M | — |
| 自由现金流率自由现金流/营收 | 6.4% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | 0.39× | — |
| 过去12个月自由现金流最近4个季度 | $205.8M | — |
8季度趋势，按日历期对齐
经营现金流EMBCKOS
| Q4 25 | $17.2M | $35.3M | ||
| Q3 25 | $84.0M | $-27.6M | ||
| Q2 25 | $81.2M | $127.2M | ||
| Q1 25 | $31.8M | $-888.0K | ||
| Q4 24 | $-5.3M | $175.7M | ||
| Q3 24 | $26.6M | $6.3M | ||
| Q2 24 | $-2.1M | $223.7M | ||
| Q1 24 | $24.3M | $272.6M |
自由现金流EMBCKOS
| Q4 25 | $16.6M | — | ||
| Q3 25 | $76.7M | — | ||
| Q2 25 | $80.8M | — | ||
| Q1 25 | $31.7M | — | ||
| Q4 24 | $-6.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-11.8M | — | ||
| Q1 24 | $20.9M | — |
自由现金流率EMBCKOS
| Q4 25 | 6.4% | — | ||
| Q3 25 | 29.1% | — | ||
| Q2 25 | 27.3% | — | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | -2.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.3% | — | ||
| Q1 24 | 7.3% | — |
资本支出强度EMBCKOS
| Q4 25 | 0.2% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 3.6% | — | ||
| Q1 24 | 1.2% | — |
现金转化率EMBCKOS
| Q4 25 | 0.39× | — | ||
| Q3 25 | 3.18× | — | ||
| Q2 25 | 1.78× | — | ||
| Q1 25 | 1.35× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.82× | 0.14× | ||
| Q2 24 | -0.14× | 3.74× | ||
| Q1 24 | 0.84× | 2.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EMBC
| Pen Needles | $185.5M | 71% |
| Safety | $37.3M | 14% |
| Syringes | $30.7M | 12% |
| Manufacturing Facility | $4.1M | 2% |
KOS
| Ghana Segment | $134.6M | 46% |
| Gulf Of America | $80.7M | 27% |
| Mauritania And Senegal | $54.9M | 19% |
| Equatorial Guinea Segment | $24.3M | 8% |
